# Riluzole to Treat Major Depression

> **NCT00026052** · PHASE2 · COMPLETED · sponsor: **National Institute of Mental Health (NIMH)** · enrollment: 31 (—)

## Conditions studied

- Depression

## Interventions

- **DRUG:** riluzole

## Key facts

- **NCT ID:** NCT00026052
- **Lead sponsor:** National Institute of Mental Health (NIMH)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-11
- **Primary completion:** —
- **Final completion:** 2003-04
- **Target enrollment:** 31 (—)
- **Last updated:** 2008-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00026052

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00026052, "Riluzole to Treat Major Depression". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00026052. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*